The DOI matches its Crossref record.
Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat
Abstract
Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear hormone receptor superfamily that can be activated by various xenobiotics and natural fatty acids. These transcription factors primarily regulate genes involved in lipid metabolism and also play a role in adipocyte differentiation. We present the expression patterns of the PPAR subtypes in the adult rat, determined by in situ hybridization using specific probes for PPAR-alpha, -beta and -gamma, and by immunohistochemistry using a polyclonal antibody that recognizes the three rat PPAR subtypes. In numerous cell types from either ectodermal, mesodermal, or endodermal origin, PPARs are coexpressed, with relative levels varying between them from one cell type to the other. PPAR-alpha is highly expressed in hepatocytes, cardiomyocytes, enterocytes, and the proximal tubule cells of kidney. PPAR-beta is expressed ubiquitously and often at higher levels than PPAR-alpha and -gamma. PPAR-gamma is expressed predominantly in adipose tissue and the immune system. Our results suggest new potential directions to investigate the functions of the different PPAR subtypes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, PPAR-γ is commonly expressed in macrophages and yields anti-inflammatory effects in liver fibrosis.[105]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [105]
Citations
Cited by
Sorted by citations
Items 501–600 of 1,005
Majdalawieh, A. F., & Ro, H.-S. (2010) · Nuclear Receptor Signaling · doi:10.1621/nrs.08004 · Cited by 94
Guri, A. J., Hontecillas, R., Ferrer, G., Casagran, O., Wankhade, U. D., Noble, A. M., Eizirik, D. L., Ortis, F., Cnop, M., Liu, D., et al. (2007) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2007.02.010 · Cited by 92
A gut feeling of the PXR, PPAR and NF‐κB connection
Wahli, W. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01951.x · Cited by 94
Self-citationBronner, M., Hertz, R., & Bar‐Tana, J. (2004) · Biochemical Journal · doi:10.1042/bj20040955 · Cited by 95
Angéli, V., Hammad, H., Staels, B., Capron, M., Lambrecht, B. N., & Trottein, F. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.5295 · Cited by 92
Iron restriction improves type 2 diabetes mellitus in Otsuka Long-Evans Tokushima fatty rats
Minamiyama, Y., Takemura, S., Kodai, S., Shinkawa, H., Tsukioka, T., Ichikawa, H., Naito, Y., Yoshikawa, T., & Okada, S. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00620.2009 · Cited by 92
Chen, A., Tang, Y., Davis, V. R., Hsu, F., Kennedy, S., Song, H., TURK, J. W., Brunt, E. M., Newberry, E. P., & Davidson, N. O. (2013) · Hepatology · doi:10.1002/hep.26318 · Cited by 90
Andersen, Ø., Eijsink, V. G. H., & Thomassen, M. S. (2000) · Gene · doi:10.1016/s0378-1119(00)00350-4 · Cited by 89
Peroxisome Proliferators‐Activated Receptor (PPAR) Modulators and Metabolic Disorders
Cho, M.-C., Lee, K., Paik, S., & Yoon, D. (2008) · PPAR Research · doi:10.1155/2008/679137 · Cited by 91
Harada, K., Isse, K., Kamihira, T., Shimoda, S., & Nakanuma, Y. (2005) · Hepatology · doi:10.1002/hep.20705 · Cited by 88
Peroxisome proliferator activated receptor agonists
Kersten, S., & Wahli, W. (2000) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0348-8393-1_9 · Cited by 89
Self-citationPPAR‐γ agonists as therapy for diseases involving airway neutrophilia
Birrell, M. A., Patel, H. J., McCluskie, K., Wong, S. M., Leonard, T. B., Yacoub, M. H., & Belvisi, M. G. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00098303 · Cited by 89
Peroxisome proliferator-activated receptor-γ ligands for the treatment of breast cancer
Fenner, M. H., & Elstner, E. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.6.557 · Cited by 88
Dietary Polyphenols: A Multifactorial Strategy to Target Alzheimer’s Disease
Dhakal, S., Kushairi, N., Phan, C., Adhikari, B., Sabaratnam, V., & Macreadie, I. G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205090 · Cited by 92
Latini, G., Scoditti, E., Verrotti, A., Felice, C. D., & Massaro, M. (2007) · PPAR Research · doi:10.1155/2008/359267 · Cited by 93
Fukuchi, Y., Hiramitsu, M., Okada, M., Hayashi, S., Nabeno, Y., Osawa, T., & Naito, M. (2008) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.2008066 · Cited by 90
Do PPARGC1A and PPARα polymorphisms influence sprint or endurance phenotypes?
Eynon, N., Meckel, Y., Sagiv, M. S., Yamin, C., Amir, R. E., Sagiv, M. S., Goldhammer, E., Duarte, J. A., & de Oliveira, J. J. F. (2010) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/j.1600-0838.2009.00930.x · Cited by 93
Vrins, C. L. J., van der Velde, A. E., van den Oever, K., Levels, J. H. M., Huet, S., Elferink, R. P. J. O., Kuipers, F., & Groen, A. K. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800579-jlr200 · Cited by 88
Anderson, S. P., Dunn, C. S., Laughter, A., Yoon, L., Swanson, C. L., Stulnig, T. M., Steffensen, K. R., Chandraratna, R. A. S., Gustafsson, J.-Å., & Corton, J. C. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.005496 · Cited by 87
Matsuura, H., Adachi, H., Smart, R. C., Xu, X., Arata, J., & Jetten, A. M. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00214-7 · Cited by 89
PFAS and Potential Adverse Effects on Bone and Adipose Tissue through Interactions with PPARγ
Kirk, A. B., Michelsen-Correa, S., Rosen, C., Martin, C. F., & Blumberg, B. (2021) · Endocrinology · doi:10.1210/endocr/bqab194 · Cited by 90
D’Aniello, E., Fellous, T. G., Iannotti, F. A., Gentile, A., Allarà, M., Balestrieri, F., Gray, R., Amodeo, P., Vitale, R. M., & Marzo, V. D. (2019) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2019.01.002 · Cited by 93
Regulation of Intestinal Inflammation by Dietary Fats
Basson, A. R., Chen, C., Sagl, F., Trotter, A., Bederman, I. R., Gomez-Nguyen, A., Sundrud, M. S., Ilić, S., Cominelli, F., & Rodriguez‐Palacios, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.604989 · Cited by 87
Connexins 43 and 26 Are Differentially Increased after Rat Bladder Outlet Obstruction
Haefliger, J. (2002) · Experimental Cell Research · doi:10.1006/excr.2001.5465 · Cited by 87
Bezafibrate is a dual ligand for PPARα and PPARβ: studies using null mice
Peters, J. M., Aoyama, T., Burns, A., & Gonzalez, F. J. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(03)00065-9 · Cited by 92
Romics, L., Kodys, K., Dolganiuc, A., Graham, L. S., Velayudham, A., Mandrekar, P., & Szabó, G. (2004) · Hepatology · doi:10.1002/hep.20304 · Cited by 87
Puhl, A. C., Milton, F. A., Čvoro, A., Sieglaff, D. H., Campos, J. C. L. D. O., Bernardes, A., Filgueira, C. S., Lindemann, J. A. L., Deng, T., Neves, F. D. A. R., et al. (2015) · Nuclear Receptor Signaling · doi:10.1621/nrs.13004 · Cited by 88
Crisóstomo, L., Alves, M. G., Gorga, A., Sousa, M., Riera, M. F., Galardo, M. N., Meroni, S. B., & Oliveira, P. F. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7698-0_11 · Cited by 90
Lipid sensing and lipid sensors
Grimaldi, P. A. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7278-5 · Cited by 89
Man, M., Barish, G. D., Schmuth, M., Crumrine, D. A., Barak, Y., Chang, S., Jiang, Y. J., Evans, R. M., Elias, P. M., & Feingold, K. R. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701026 · Cited by 86
Review: PPARs as new therapeutic targets for the treatment of cerebral ischemia/reperfusion injury
Collino, M., Patel, N. S. A., & Thiemermann, C. (2008) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944708090924 · Cited by 87
Yokoyama, Y., Xin, B., Shigeto, T., Umemoto, M., Kasai-Sakamoto, A., Futagami, M., Tsuchida, S., Al‐Mulla, F., & Mizunuma, H. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0722 · Cited by 86
The impact of PPARα activation on whole genome gene expression in human precision cut liver slices
Janssen, A. W. F., Betzel, B., Stoopen, G. M., Berends, F. J., Janssen, I. M. C., Peijnenburg, A., & Kersten, S. (2015) · BMC Genomics · doi:10.1186/s12864-015-1969-3 · Cited by 85
Bhattacharya, P., & Keating, A. F. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.04.009 · Cited by 87
Huin‐Schohn, C., Corriveau, L., Bianchi, A., Keller, J. M., Collet, P., Krémarik, P., Domenjoud, L., Bécuwe, P., Schohn, H., Ménard, D., et al. (2000) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540004800504 · Cited by 85
Self-citationExpression of Peroxisome Proliferator-Activated Receptor γ (PPARγ) in Rat Aortic Smooth Muscle Cells
Iijima, K., Yoshizumi, M., Ako, J., Eto, M., Kim, S., Hashimoto, M., Sugimoto, N., Liang, Y.-Q., Sudoh, N., Toba, K., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8794 · Cited by 85
Joss‐Moore, L. A., Wang, Y., Baack, M. L., Yao, J., Norris, A. W., Yu, X., Callaway, C. W., McKnight, R. A., Albertine, K. H., & Lane, R. H. (2010) · Early Human Development · doi:10.1016/j.earlhumdev.2010.08.026 · Cited by 84
Integrative and Systemic Approaches for Evaluating PPARβ/δ (PPARD) Function
Attianese, G. M. P. G., & Desvergne, B. (2015) · Nuclear Receptor Signaling · doi:10.1621/nrs.13001 · Cited by 88
Vallée, A., Vallée, J.-N., Guillevin, R., & Lecarpentier, Y. (2017) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-017-0550-9 · Cited by 88
Hu, X., Wang, Y., Wang, J., Xue, Y., Li, Z., Nagao, K., Yanagita, T., & Xue, C. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-25 · Cited by 85
Afif, H., Benderdour, M., Endam, L. M., Martel‐Pelletier, J., Pelletier, J., Duval, N., & Fahmi, H. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2151 · Cited by 84
Nakashiro, K., Hayashi, Y., Kita, A., Tamatani, T., Chlenski, A., Usuda, N., Hattori, K., Reddy, J. K., & Oyasu, R. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61730-0 · Cited by 84
Gupta, D., Kono, T., & Evans‐Molina, C. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01299.x · Cited by 83
The peroxisome proliferator-activated receptors at the cross-road of diet and hormonal signalling
Desvergne, B., Ijpenberg, A., Devchand, P. R., & Wahli, W. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00182-9 · Cited by 83
Self-citationMandard, S., & Patsouris, D. (2013) · PPAR Research · doi:10.1155/2013/613864 · Cited by 84
Immunohistochemistry in Investigative and Toxicologic Pathology
Janardhan, K. S., Jensen, H. L., Clayton, N. P., & Herbert, R. A. (2018) · Toxicologic Pathology · doi:10.1177/0192623318776907 · Cited by 88
Zhang, H.-L., Xu, M., Wei, C., Qin, A.-P., Liu, C.-F., Hong, L.-Z., Zhao, X., Liu, J., & Qin, Z. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.12.029 · Cited by 83
Ibabe, A., Bilbao, E., & Cajaraville, M. P. (2004) · Histochemistry and Cell Biology · doi:10.1007/s00418-004-0737-2 · Cited by 83
Kostiuk, M. A., Keller, B. O., & Berthiaume, L. G. (2010) · The FASEB Journal · doi:10.1096/fj.09-149765 · Cited by 85
Flavell, D. M., Ireland, H., Stephens, J. W., Hawe, E., Acharya, J., Mather, H. M., Hurel, S. J., & Humphries, S. E. (2005) · Diabetes · doi:10.2337/diabetes.54.2.582 · Cited by 83
Cui, H., Zheng, M., Zhao, G., Liu, R., & Wen, J. (2018) · BMC Genomics · doi:10.1186/s12864-017-4292-3 · Cited by 83
Endocannabinoid System in Hepatic Glucose Metabolism, Fatty Liver Disease, and Cirrhosis
Bazwinsky‐Wutschke, I., Zipprich, A., & Dehghani, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102516 · Cited by 85
O-GlcNAc modification of PPARγ reduces its transcriptional activity
Ji, S., Park, S., Roth, J., Kim, H. S., & Cho, J. W. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.12.086 · Cited by 84
Modulating the transcriptional control of adipogenesis
Loftus, T. M., & Lane, M. D. (1997) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(97)80006-8 · Cited by 82
Response of Experimental Retinal Neovascularization to Thiazolidinediones
Murata, T. (2001) · Archives of Ophthalmology · doi:10.1001/archopht.119.5.709 · Cited by 82
Hou, X., Shen, Y. H., Li, C., Wang, F., Zhang, C., Bu, P., & Zhang, Y. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.043 · Cited by 81
Ferruzzi, P., Ceni, E., Tarocchi, M., Grappone, C., Milani, S., Galli, A., Fiorelli, G., Serio, M., & Mannelli, M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0978 · Cited by 81
Jitrapakdee, S., Slawik, M., Medina‐Gómez, G., Campbell, M., Wallace, J. C., Sethi, J. K., O’Rahilly, S., & Vidal‐Puig, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503836200 · Cited by 82
Duszka, K., Gregor, A., Guillou, H., König, J. S., & Wahli, W. (2020) · Cells · doi:10.3390/cells9071708 · Cited by 86
Self-citationPPAR-Targeted Therapies in the Treatment of Non-Alcoholic Fatty Liver Disease in Diabetic Patients
Lange, N. F., Graf, V., Caussy, C., & Dufour, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084305 · Cited by 84
Cristiano, L., Bernardo, A., & Ceru`, M. P. (2001) · Journal of Neurocytology · doi:10.1023/a:1016525716209 · Cited by 81
Zhu, R., Wu, M.-Q., Li, Z., Zhang, Y., & Liu, K. (2012) · International Journal of Hematology · doi:10.1007/s12185-012-1233-4 · Cited by 80
PPARγ and metabolism: insights from the study of human genetic variants
Gurnell, M. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01767.x · Cited by 80
Xu, L., Han, C. L., Lim, K., & Wu, T. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1445 · Cited by 84
Metabolomics of the interaction between PPAR‐α and age in the PPAR‐α‐null mouse
Atherton, H. J., Gulston, M. K., Bailey, N. J. C., Cheng, K., Zhang, W., Clarke, K., & Griffin, J. L. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.18 · Cited by 80
Gloerich, J., van Vlies, N., Jansen, G. A., Denis, S. W., Ruiter, J. P. N., van Werkhoven, M. A., Durán, M., Vaz, F. M., Wanders, R. J. A., & Ferdinandusse, S. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400337-jlr200 · Cited by 80
The potential interactions between polyunsaturated fatty acids and colonic inflammatory processes
Mills, S., Windsor, A. C. J., & Knight, S. C. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02851.x · Cited by 81
Brusotti, G., Montanari, R., Capelli, D., Cattaneo, G., Laghezza, A., Tortorella, P., Loiodice, F., Peiretti, F., Bonardo, B., Paiardini, A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05666-6 · Cited by 84
Van, L. V., Pham, E. C., Nguyen, C. V., Duong, N. T. N., Thi, T. V. L., & Truong, T. N. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112611 · Cited by 87
The Roles of Peroxisome Proliferator-Activated Receptors in the Metabolic Syndrome
Mansour, M. M. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800101-1.00007-7 · Cited by 81
Perfluorooctanoic acid-induced hepatic toxicity following 21-day oral exposure in mice
Son, H., Kim, S.-H., Shin, H., Bae, H. I., & Yang, J. (2007) · Archives of Toxicology · doi:10.1007/s00204-007-0246-x · Cited by 79
Liu, Y., Heymann, R. S., Moatamed, F., Schultz, J. J., Sobel, D., & Brent, G. A. (2006) · Endocrinology · doi:10.1210/en.2006-0836 · Cited by 79
Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTEN
Piguet, A., Stroka, D., Zimmermann, A., & Dufour, J. (2009) · Clinical Science · doi:10.1042/cs20090313 · Cited by 79
Latruffe, N., Cherkaoui‐Malki, M., Nicolas-Francès, V., Clémencet, M.-C., Jannin, B., & Berlot, J. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00416-0 · Cited by 80
Peroxisome Proliferator‐Activated Receptor β/δ in the Brain: Facts and Hypothesis
Hall, M. G., Quignodon, L., & Desvergne, B. (2008) · PPAR Research · doi:10.1155/2008/780452 · Cited by 80
Anderson, S. P., Howroyd, P. C., Liu, J., Qian, X., Bahnemann, R., Swanson, C. L., Kwak, M.-K., Kensler, T. W., & Corton, J. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409347200 · Cited by 79
Edvardsson, U., von Löwenhielm, H. B., Panfilov, O., Nyström, A., Nilsson, F. Y., & Dahllöf, B. (2003) · PROTEOMICS · doi:10.1002/pmic.200390061 · Cited by 81
Asano, T., Wakisaka, M., Yoshinari, M., Iino, K., Sonoki, K., Iwase, M., & Fujishima, M. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(00)00054-9 · Cited by 79
Gbaguidi, F. G., Chinetti, G., Milosavljevic, D., Morier-teissier, E., Chapman, J., Olivecrona, G., Fruchart, J., Griglio, S., Fruchart, J., & Staels, B. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02223-8 · Cited by 79
TRANSCRIPTIONAL ACTIVATION OF CYTOCHROME P450 GENES BY DIFFERENT CLASSES OF CHEMICAL INDUCERS
Dogra, S. C., Whitelaw, M. L., & May, B. K. (1998) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1998.tb02135.x · Cited by 78
Hanging Drop, A Best Three-Dimensional (3D) Culture Method for Primary Buffalo and Sheep Hepatocytes
Shri, M., Agrawal, H., Rani, P., Singh, D., & Onteru, S. K. (2017) · Scientific Reports · doi:10.1038/s41598-017-01355-6 · Cited by 80
Duke, K. S., & Bonner, J. C. (2017) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1498 · Cited by 80
Boukouvala, E., Antonopoulou, E., Favre‐Krey, L., Díez, A., Bautista, J. M., Leaver, M. J., Tocher, D. R., & Krey, G. D. (2004) · Lipids · doi:10.1007/s11745-004-1334-z · Cited by 78
Arakawa, R., Tamehiro, N., Nishimaki‐Mogami, T., Ueda, K., & Yokoyama, S. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000163844.07815.c4 · Cited by 79
Kummer, M. P., & Heneka, M. T. (2008) · PPAR Research · doi:10.1155/2008/403896 · Cited by 78
Polyunsaturated fatty acids stimulate hepatic UCP-2 expression via a PPARα-mediated pathway
Armstrong, M. B., & Towle, H. C. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1197 · Cited by 78
Thiazolidinedione Treatment Prevents Free Fatty Acid–Induced Insulin Resistance in Male Wistar Rats
Hevener, A. L., Reichart, D. R., Janež, A., & Olefsky, J. M. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2316 · Cited by 78
The expression of C-FABP and PPARγ and their prognostic significance in prostate cancer
Forootan, F. S., Forootan, S. S., Malki, M. I., Chen, D., Li, G., Lin, K., Rudland, P. S., Foster, C. S., & Ke, Y. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2166 · Cited by 77
Akimoto, Y., Kreppel, L. K., Hirano, H., & Hart, G. W. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2331 · Cited by 77
Repression of IFN-γ Expression by Peroxisome Proliferator-Activated Receptor γ
Cunard, R. A., Eto, Y., Muljadi, J. T., Glass, C. K., Kelly, C., & Ricote, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7530 · Cited by 78
Houston, K. D., Copland, J. A., Broaddus, R. R., Gottardis, M. M., Fischer, S. M., & Walker, C. L. (2003) · PubMed · Cited by 77
Roberts‐Thomson, S. J. (2000) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.2000.00921.x · Cited by 75
Theocharis, S. E., Kanelli, H., Politi, E. N., Margeli, A. P., Karkandaris, C., Philipides, T., & Koutselinis, A. S. (2002) · Lung Cancer · doi:10.1016/s0169-5002(02)00013-2 · Cited by 76
Transcriptional regulation of metabolic processes: implications for cardiac metabolism
van Bilsen, M., Vusse, G. J., & Reneman, R. S. (1998) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240050739 · Cited by 76
Staels, B., Schoonjans, K., Fruchart, J., & Auwerx, J. H. (1997) · Biochimie · doi:10.1016/s0300-9084(97)81497-6 · Cited by 79
Han, S. W., Greene, M. E., Pitts, J., Wada, R. K., & Sidell, N. (2001) · PubMed · Cited by 77
Qi, C., Zhu, Y., Pan, J., Yeldandi, A. V., Rao, M. S., Maeda, N., Subbarao, V., Pulikuri, S., Hashimoto, T., & Reddy, J. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1585 · Cited by 77
Chevillotte, E., Rieusset, J., Roques, M., Desage, M., & Vidal, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008010200 · Cited by 77
Qiang, J., Tao, Y. F., Bao, J. W., Chen, D. J., Li, H. X., He, J., & Xu, P. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01422 · Cited by 76
Hermo, L., Pelletier, R. ‐., Cyr, D. G., & Smith, C. E. (2009) · Microscopy Research and Technique · doi:10.1002/jemt.20786 · Cited by 80
Metadata
- Authors
- Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W.
- Affiliations
- University of Lausanne (CH)
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1996-01
- Volume
- 137
- Issue
- 1
- Pages
- 354-366
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2047982128
- Cited by
- 2,217
- References
- 0
- Citations by year
- 2026: 14 · 2025: 34 · 2024: 31 · 2023: 32 · 2022: 56 · 2021: 53 · 2020: 50 · 2019: 42 · 2018: 74 · 2017: 64 · 2016: 76 · 2015: 65 · 2014: 75 · 2013: 95 · 2012: 71
- FWCI
- 23.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- peroxisome proliferator-activated receptors, PPARα, PPAR-beta, PPARγ, tissue distribution, nuclear receptors, lipid metabolism, adipogenesis, hepatocytes, cardiomyocytes, enterocytes, proximal tubular epithelial cells, adipose tissue, immune system, rats
- MeSH terms
- Animals, Base Sequence, Female, Male, Molecular Sequence Data, Tissue Distribution, Transcription Factors, Molecular Probes, Rats, Sprague-Dawley, In Situ Hybridization, Receptors, Cytoplasmic and Nuclear, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review